Literature DB >> 10773883

GA-binding protein alpha/beta is a critical regulator of the BRCA1 promoter.

E Atlas1, M Stramwasser, K Whiskin, C R Mueller.   

Abstract

Decreased expression of BRCA1 may play a role in the etiology of sporadic breast cancer. Deletion and point mutant analysis of proximal promoter elements in the BRCA1 1a promoter revealed a 22 bp region which was critical for the expression of the promoter in MCF-7 cells, but had a much reduced effect in T47D cells. The main transcription factor interacting with this site was identified as GABPalpha/beta, and a discrete DNA binding complex was only observed in nuclear extracts from MCF-7 cells. Cotransfection experiments with GABPalpha and beta1 expression vectors produced transactivation of this element in both lines. These results suggest that GABPalpha/beta is a critical activator of BRCA1 expression, and that its activity may differ in human breast cell lines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773883     DOI: 10.1038/sj.onc.1203516

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

Review 1.  The ETS family of oncogenic transcription factors in solid tumours.

Authors:  Gina M Sizemore; Jason R Pitarresi; Subhasree Balakrishnan; Michael C Ostrowski
Journal:  Nat Rev Cancer       Date:  2017-04-28       Impact factor: 60.716

Review 2.  The dual lives of bidirectional promoters.

Authors:  Clay Wakano; Jung S Byun; Li-Jun Di; Kevin Gardner
Journal:  Biochim Biophys Acta       Date:  2012-02-21

Review 3.  Beyond the histone tale: HP1α deregulation in breast cancer epigenetics.

Authors:  Johan Vad-Nielsen; Anders Lade Nielsen
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

4.  Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach.

Authors:  C Beger; L N Pierce; M Kruger; E G Marcusson; J M Robbins; P Welcsh; P J Welch; K Welte; M C King; J R Barber; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

5.  Abnormal expression of NRF-2α in hepatocellular carcinoma identified with a newly prepared monoclonal antibody against human NRF-2α protein.

Authors:  Ya Qing Zhang; Kai Nan Li; Ji Hong Cui; Yan Fang Liu; Shou Jing Yang
Journal:  Mol Biol Rep       Date:  2010-02-03       Impact factor: 2.316

6.  c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells.

Authors:  Yinghua Chen; Jinhua Xu; Stanley Borowicz; Cindy Collins; Dezheng Huo; Olufunmilayo I Olopade
Journal:  BMC Cancer       Date:  2011-06-13       Impact factor: 4.430

7.  Decreased expression of BRCA1 in SK-BR-3 cells is the result of aberrant activation of the GABP Beta promoter by an NRF-1-containing complex.

Authors:  Crista Thompson; Gwen MacDonald; Christopher R Mueller
Journal:  Mol Cancer       Date:  2011-05-24       Impact factor: 27.401

8.  Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation.

Authors:  M-H Lee; T Lahusen; R-H Wang; C Xiao; X Xu; Y-S Hwang; W-W He; Y Shi; C-X Deng
Journal:  Oncogene       Date:  2011-06-13       Impact factor: 8.756

9.  Characterization of a negative transcriptional element in the BRCA1 promoter.

Authors:  Gwen MacDonald; Melissa Stramwasser; Christopher R Mueller
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

Review 10.  The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer.

Authors:  Marcia L McCoy; Christopher R Mueller; Calvin D Roskelley
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.